Dataset Viewer
Auto-converted to Parquet Duplicate
text
stringlengths
377
3.32k
{"timestamp": "2025-07-18 11:47:28.727", "mode": "azero-full", "language": "en", "target": "en", "text": "Welcome to the AbbVie First Quarter twenty twenty five Earnings Conference Call. All participants will be able to listen only until the question and answer portion of this call. You may ask a question by pressing Star one on your phone. As a reminder, this call is being recorded. I would now like to introduce Miss Shea Senior", "text_tts": "rded I would now like to introduce Miss Shea Senior", "translate": "Welcome to the AbbVie First Quarter twenty twenty five Earnings Conference Call. All participants will be able to listen only until the question and answer portion of this call. You may ask a question by pressing Star one on your phone. As a reminder, this call is being recorded. I would now like to introduce Miss Shea Senior", "translate_tts": "Welcome to the AbbVie First Quarter twenty twenty five Earnings Conference Call All participants will be able to listen only until the question and answer portion of this call You may ask a question by pressing Star one on your phone As a reminder this call is being recorded I would now like to introduce Miss Shea Senior", "is_final": false, "emotion": "", "events": "🤖🗣👩📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Miss Shea (Investor Relations VP)", "text_emotion": "none"}
{"timestamp": "2025-07-18 11:47:30.626", "mode": "azero-full", "language": "en", "target": "en", "text": "Vice President, Investor Relations.", "text_tts": "Investor Relations", "translate": "Vice President, Investor Relations.", "translate_tts": "Vice President Investor Relations", "is_final": false, "emotion": "", "events": "📞👂", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Miss Shea (Investor Relations VP)", "text_emotion": "none"}
{"timestamp": "2025-07-18 11:47:45.873", "mode": "azero-full", "language": "en", "target": "en", "text": "Good morning, and thanks for joining us. Also on the call with me today are Rob Michael, Chief Executive Officer, Jeff Stewart, Executive Vice President, Chief Commercial Officer, Rupel Thackar, Executive Vice President, Research and Development, Chief Scientific Officer, and Scott Rentz, Executive", "text_tts": "ment Chief Scientific Officer and Scott Rentz Executive", "translate": "Good morning, and thanks for joining us. Also on the call with me today are Rob Michael, Chief Executive Officer, Jeff Stewart, Executive Vice President, Chief Commercial Officer, Rupel Thackar, Executive Vice President, Research and Development, Chief Scientific Officer, and Scott Rentz, Executive", "translate_tts": "Good morning and thanks for joining us Also on the call with me today are Rob Michael Chief Executive Officer Jeff Stewart Executive Vice President Chief Commercial Officer Rupel Thackar Executive Vice President Research and Development Chief Scientific Officer and Scott Rentz Executive", "is_final": false, "emotion": "😊", "events": "👩📯🤖🗣", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Miss Shea (Investor Relations VP)", "text_emotion": "none"}
{"timestamp": "2025-07-18 11:47:47.699", "mode": "azero-full", "language": "en", "target": "en", "text": "President, Chief Financial Officer.", "text_tts": "Officer", "translate": "President, Chief Financial Officer.", "translate_tts": "President Chief Financial Officer", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Miss Shea (Investor Relations VP)", "text_emotion": "none"}
{"timestamp": "2025-07-18 11:48:02.302", "mode": "azero-full", "language": "en", "target": "en", "text": "Before we get started, I'll note that some statements we make today may be considered forward looking statements based on our current expectations. AbbVie cautions that these forward looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in our forward looking statements.", "text_tts": "r forward looking statements", "translate": "Before we get started, I'll note that some statements we make today may be considered forward looking statements based on our current expectations. AbbVie cautions that these forward looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in our forward looking statements.", "translate_tts": "Before we get started Ill note that some statements we make today may be considered forward looking statements based on our current expectations AbbVie cautions that these forward looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in our forward looking statements", "is_final": false, "emotion": "😊", "events": "👩📯🤖🗣", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Miss Shea (Investor Relations VP)", "text_emotion": "none"}
{"timestamp": "2025-07-18 11:48:06.612", "mode": "azero-full", "language": "en", "target": "en", "text": "Additional information about these risks and uncertainties is included in our SEC filings.", "text_tts": "in our SEC filings", "translate": "Additional information about these risks and uncertainties is included in our SEC filings.", "translate_tts": "Additional information about these risks and uncertainties is included in our SEC filings", "is_final": false, "emotion": "", "events": "📞🌠", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Miss Shea (Investor Relations VP)", "text_emotion": "none"}
{"timestamp": "2025-07-18 11:48:10.784", "mode": "azero-full", "language": "en", "target": "en", "text": "Abby undertakes no obligation to update these forward looking statements, except as required by law.", "text_tts": "except as required by law", "translate": "Abby undertakes no obligation to update these forward looking statements, except as required by law.", "translate_tts": "Abby undertakes no obligation to update these forward looking statements except as required by law", "is_final": false, "emotion": "", "events": "📞🌠👩📯🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Miss Shea (Investor Relations VP)", "text_emotion": "none"}
{"timestamp": "2025-07-18 11:48:24.555", "mode": "azero-full", "language": "en", "target": "en", "text": "On today's conference call, non GAAP financial measures will be used to help investors understand Abbey's business performance. These non GAAP financial measures are reconciled with comparable GAAP financial measures in our earnings release and regulatory filings from today, which can be found on our website.", "text_tts": "nd on our website", "translate": "On today's conference call, non GAAP financial measures will be used to help investors understand Abbey's business performance. These non GAAP financial measures are reconciled with comparable GAAP financial measures in our earnings release and regulatory filings from today, which can be found on our website.", "translate_tts": "On todays conference call non GAAP financial measures will be used to help investors understand Abbeys business performance These non GAAP financial measures are reconciled with comparable GAAP financial measures in our earnings release and regulatory filings from today which can be found on our website", "is_final": false, "emotion": "", "events": "🤖🗣👩📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Miss Shea (Investor Relations VP)", "text_emotion": "none"}
{"timestamp": "2025-07-18 11:48:31.171", "mode": "azero-full", "language": "en", "target": "en", "text": "Following our prepared remarks, we'll take your questions. So with that, I'll turn the call over to Rob. Thank you, Liz.", "text_tts": "k you Liz", "translate": "Following our prepared remarks, we'll take your questions. So with that, I'll turn the call over to Rob. Thank you, Liz.", "translate_tts": "Following our prepared remarks well take your questions So with that Ill turn the call over to Rob Thank you Liz", "is_final": false, "emotion": "", "events": "📞🌠💬👂🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Miss Shea (Investor Relations VP)", "text_emotion": "none"}
{"timestamp": "2025-07-18 11:48:33.739", "mode": "azero-full", "language": "en", "target": "en", "text": "Good morning, everyone, and thank you for joining us.", "text_tts": "and thank you for joining us", "translate": "Good morning, everyone, and thank you for joining us.", "translate_tts": "Good morning everyone and thank you for joining us", "is_final": false, "emotion": "😊", "events": "📞🌠🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "surprise"}
{"timestamp": "2025-07-18 11:48:37.131", "mode": "azero-full", "language": "en", "target": "en", "text": "AbbVie is off to an excellent start to the year.", "text_tts": "is off to an excellent start to the year", "translate": "AbbVie is off to an excellent start to the year.", "translate_tts": "AbbVie is off to an excellent start to the year", "is_final": false, "emotion": "😊", "events": "🤖🗣👨📯🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:48:43.495", "mode": "azero-full", "language": "en", "target": "en", "text": "with first quarter results exceeding expectations across several of our therapeutic areas.", "text_tts": "therapeutic areas", "translate": "with first quarter results exceeding expectations across several of our therapeutic areas.", "translate_tts": "with first quarter results exceeding expectations across several of our therapeutic areas", "is_final": false, "emotion": "😊", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:48:54.102", "mode": "azero-full", "language": "en", "target": "en", "text": "We also continue to advance our promising internal pipeline and add external opportunities to further strengthen our business and long term outlook.", "text_tts": "outlook", "translate": "We also continue to advance our promising internal pipeline and add external opportunities to further strengthen our business and long term outlook.", "translate_tts": "We also continue to advance our promising internal pipeline and add external opportunities to further strengthen our business and long term outlook", "is_final": false, "emotion": "😊", "events": "🤖🗣👨📯🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:48:57.010", "mode": "azero-full", "language": "en", "target": "en", "text": "Turning to our first quarter performance.", "text_tts": "arter performance", "translate": "Turning to our first quarter performance.", "translate_tts": "Turning to our first quarter performance", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "none"}
{"timestamp": "2025-07-18 11:49:02.003", "mode": "azero-full", "language": "en", "target": "en", "text": "we delivered adjusted earnings per share of two dollars forty six cents.", "text_tts": "dollars forty six cents", "translate": "we delivered adjusted earnings per share of two dollars forty six cents.", "translate_tts": "we delivered adjusted earnings per share of two dollars forty six cents", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "none"}
{"timestamp": "2025-07-18 11:49:05.331", "mode": "azero-full", "language": "en", "target": "en", "text": "which is ten cents above our guidance midpoint.", "text_tts": "n cents above our guidance midpoint", "translate": "which is ten cents above our guidance midpoint.", "translate_tts": "which is ten cents above our guidance midpoint", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:49:14.519", "mode": "azero-full", "language": "en", "target": "en", "text": "Total net revenues were more than thirteen point three billion dollars, nearly five hundred fifty million ahead of our expectations.", "text_tts": "hundred fifty million ahead of our expectations", "translate": "Total net revenues were more than thirteen point three billion dollars, nearly five hundred fifty million ahead of our expectations.", "translate_tts": "Total net revenues were more than thirteen point three billion dollars nearly five hundred fifty million ahead of our expectations", "is_final": false, "emotion": "", "events": "🤖🗣👨📯🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:49:18.912", "mode": "azero-full", "language": "en", "target": "en", "text": "I'm especially pleased with the performance of our XHUMIRA platform.", "text_tts": "XHUMIRA platform", "translate": "I'm especially pleased with the performance of our XHUMIRA platform.", "translate_tts": "Im especially pleased with the performance of our XHUMIRA platform", "is_final": false, "emotion": "😊", "events": "📞🌠👨📯🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:49:23.389", "mode": "azero-full", "language": "en", "target": "en", "text": "which delivered robust sales growth of more than twenty one percent.", "text_tts": "twenty one percent", "translate": "which delivered robust sales growth of more than twenty one percent.", "translate_tts": "which delivered robust sales growth of more than twenty one percent", "is_final": false, "emotion": "", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:49:31.930", "mode": "azero-full", "language": "en", "target": "en", "text": "immunology, neuroscience, oncology and aesthetics are all performing at or above our expectations.", "text_tts": "t or above our expectations", "translate": "immunology, neuroscience, oncology and aesthetics are all performing at or above our expectations.", "translate_tts": "immunology neuroscience oncology and aesthetics are all performing at or above our expectations", "is_final": false, "emotion": "", "events": "🤖🗣👨📯🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:49:41.000", "mode": "azero-full", "language": "en", "target": "en", "text": "and we are well positioned to exceed our previous peak revenue in just the second full year following the US HUMIRA LOE.", "text_tts": "year following the US HUMIRA LOE", "translate": "and we are well positioned to exceed our previous peak revenue in just the second full year following the US HUMIRA LOE.", "translate_tts": "and we are well positioned to exceed our previous peak revenue in just the second full year following the US HUMIRA LOE", "is_final": false, "emotion": "😊", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:49:50.403", "mode": "azero-full", "language": "en", "target": "en", "text": "Based on this strong performance, we are raising our full year adjusted earnings per share guidance by ten cents.", "text_tts": "ten cents", "translate": "Based on this strong performance, we are raising our full year adjusted earnings per share guidance by ten cents.", "translate_tts": "Based on this strong performance we are raising our full year adjusted earnings per share guidance by ten cents", "is_final": false, "emotion": "", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:49:58.340", "mode": "azero-full", "language": "en", "target": "en", "text": "and now expect adjusted EPS between twelve dollars nine cents and twelve dollars twenty nine cents.", "text_tts": "rs nine cents and twelve dollars twenty nine cents", "translate": "and now expect adjusted EPS between twelve dollars nine cents and twelve dollars twenty nine cents.", "translate_tts": "and now expect adjusted EPS between twelve dollars nine cents and twelve dollars twenty nine cents", "is_final": false, "emotion": "", "events": "🤖🗣👨📯🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:50:00.121", "mode": "azero-full", "language": "en", "target": "en", "text": "As you are aware,", "text_tts": "As you are aware", "translate": "As you are aware,", "translate_tts": "As you are aware", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "none"}
{"timestamp": "2025-07-18 11:50:03.708", "mode": "azero-full", "language": "en", "target": "en", "text": "there is speculation that sectoral tariffs could be forthcoming.", "text_tts": "that sectoral tariffs could be forthcoming", "translate": "there is speculation that sectoral tariffs could be forthcoming.", "translate_tts": "there is speculation that sectoral tariffs could be forthcoming", "is_final": false, "emotion": "", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "fear"}
{"timestamp": "2025-07-18 11:50:10.176", "mode": "azero-full", "language": "en", "target": "en", "text": "any related impact from these tariffs as well as other potential new or reciprocal tariffs,", "text_tts": "other potential new or reciprocal tariffs", "translate": "any related impact from these tariffs as well as other potential new or reciprocal tariffs,", "translate_tts": "any related impact from these tariffs as well as other potential new or reciprocal tariffs", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "fear"}
{"timestamp": "2025-07-18 11:50:13.032", "mode": "azero-full", "language": "en", "target": "en", "text": "have not been contemplated in our guidance.", "text_tts": "contemplated in our guidance", "translate": "have not been contemplated in our guidance.", "translate_tts": "have not been contemplated in our guidance", "is_final": false, "emotion": "😡", "events": "🏠🔊📞🌠", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "fear"}
{"timestamp": "2025-07-18 11:50:18.425", "mode": "azero-full", "language": "en", "target": "en", "text": "To the extent there is an impact, we believe it would be in line with our peers.", "text_tts": "would be in line with our peers", "translate": "To the extent there is an impact, we believe it would be in line with our peers.", "translate_tts": "To the extent there is an impact we believe it would be in line with our peers", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "fear"}
{"timestamp": "2025-07-18 11:50:23.326", "mode": "azero-full", "language": "en", "target": "en", "text": "given that Abbie has an extensive manufacturing presence in the United States.", "text_tts": "e in the United States", "translate": "given that Abbie has an extensive manufacturing presence in the United States.", "translate_tts": "given that Abbie has an extensive manufacturing presence in the United States", "is_final": false, "emotion": "😮", "events": "👨📯🤖🗣", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "fear"}
{"timestamp": "2025-07-18 11:50:28.535", "mode": "azero-full", "language": "en", "target": "en", "text": "including API, biologics, toxins and small molecules.", "text_tts": "PI biologics toxins and small molecules", "translate": "including API, biologics, toxins and small molecules.", "translate_tts": "including API biologics toxins and small molecules", "is_final": false, "emotion": "", "events": "📞🌠👨📯🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "fear"}
{"timestamp": "2025-07-18 11:50:41.584", "mode": "azero-full", "language": "en", "target": "en", "text": "And over the next decade, we anticipate investing more than ten billion dollars of capital in the US to support our volume growth and our expansion into new areas such as obesity.", "text_tts": "reas such as obesity", "translate": "And over the next decade, we anticipate investing more than ten billion dollars of capital in the US to support our volume growth and our expansion into new areas such as obesity.", "translate_tts": "And over the next decade we anticipate investing more than ten billion dollars of capital in the US to support our volume growth and our expansion into new areas such as obesity", "is_final": false, "emotion": "", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "fear"}
{"timestamp": "2025-07-18 11:50:45.132", "mode": "azero-full", "language": "en", "target": "en", "text": "Turning back to our performance.", "text_tts": "performance", "translate": "Turning back to our performance.", "translate_tts": "Turning back to our performance", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "none"}
{"timestamp": "2025-07-18 11:50:53.937", "mode": "azero-full", "language": "en", "target": "en", "text": "I'm very pleased with the excellent progress we are making with several pipeline programs that have the potential to be meaningful sources of growth.", "text_tts": "sources of growth", "translate": "I'm very pleased with the excellent progress we are making with several pipeline programs that have the potential to be meaningful sources of growth.", "translate_tts": "Im very pleased with the excellent progress we are making with several pipeline programs that have the potential to be meaningful sources of growth", "is_final": false, "emotion": "😊", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:50:55.282", "mode": "azero-full", "language": "en", "target": "en", "text": "These include,", "text_tts": "These include", "translate": "These include,", "translate_tts": "These include", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:50:58.768", "mode": "azero-full", "language": "en", "target": "en", "text": "lutecizumab across several immunology indications.", "text_tts": "ab across several immunology indications", "translate": "lutecizumab across several immunology indications.", "translate_tts": "lutecizumab across several immunology indications", "is_final": false, "emotion": "", "events": "📞🌠👨📯🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:51:01.769", "mode": "azero-full", "language": "en", "target": "en", "text": "three hundred and eighty three and multiple myeloma.", "text_tts": "ndred and eighty three and multiple myeloma", "translate": "three hundred and eighty three and multiple myeloma.", "translate_tts": "three hundred and eighty three and multiple myeloma", "is_final": false, "emotion": "", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:51:12.074", "mode": "azero-full", "language": "en", "target": "en", "text": "and our next generation ADCs, including TMAB A for several solid tumor types and seven hundred and six for small cell lung cancer.", "text_tts": "nd seven hundred and six for small cell lung cancer", "translate": "and our next generation ADCs, including TMAB A for several solid tumor types and seven hundred and six for small cell lung cancer.", "translate_tts": "and our next generation ADCs including TMAB A for several solid tumor types and seven hundred and six for small cell lung cancer", "is_final": false, "emotion": "", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:51:20.289", "mode": "azero-full", "language": "en", "target": "en", "text": "We also continue to add depth to our pipeline with strategic transactions that can help drive growth in the next decade.", "text_tts": "drive growth in the next decade", "translate": "We also continue to add depth to our pipeline with strategic transactions that can help drive growth in the next decade.", "translate_tts": "We also continue to add depth to our pipeline with strategic transactions that can help drive growth in the next decade", "is_final": false, "emotion": "😊", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:51:27.896", "mode": "azero-full", "language": "en", "target": "en", "text": "This includes the recent acquisition of Nimble Therapeutics to expand our immunology portfolio with oral peptides.", "text_tts": "with oral peptides", "translate": "This includes the recent acquisition of Nimble Therapeutics to expand our immunology portfolio with oral peptides.", "translate_tts": "This includes the recent acquisition of Nimble Therapeutics to expand our immunology portfolio with oral peptides", "is_final": false, "emotion": "", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:51:34.345", "mode": "azero-full", "language": "en", "target": "en", "text": "as well as the license agreement with Gubra to develop an AMYLIN analog for the treatment of obesity.", "text_tts": "of obesity", "translate": "as well as the license agreement with Gubra to develop an AMYLIN analog for the treatment of obesity.", "translate_tts": "as well as the license agreement with Gubra to develop an AMYLIN analog for the treatment of obesity", "is_final": false, "emotion": "", "events": "📞🌠👨📯🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:51:40.720", "mode": "azero-full", "language": "en", "target": "en", "text": "Obesity represents a significant global health concern with high unmet need.", "text_tts": "with high unmet need", "translate": "Obesity represents a significant global health concern with high unmet need.", "translate_tts": "Obesity represents a significant global health concern with high unmet need", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:51:51.373", "mode": "azero-full", "language": "en", "target": "en", "text": "This market will continue to evolve with improved offerings, and we believe our program with Gubra has the potential to deliver a differentiated asset.", "text_tts": "er a differentiated asset", "translate": "This market will continue to evolve with improved offerings, and we believe our program with Gubra has the potential to deliver a differentiated asset.", "translate_tts": "This market will continue to evolve with improved offerings and we believe our program with Gubra has the potential to deliver a differentiated asset", "is_final": false, "emotion": "", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:51:59.591", "mode": "azero-full", "language": "en", "target": "en", "text": "Going forward, we plan to invest further in obesity, along with other opportunities across our existing five key growth areas.", "text_tts": "existing five key growth areas", "translate": "Going forward, we plan to invest further in obesity, along with other opportunities across our existing five key growth areas.", "translate_tts": "Going forward we plan to invest further in obesity along with other opportunities across our existing five key growth areas", "is_final": false, "emotion": "😊", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:52:04.024", "mode": "azero-full", "language": "en", "target": "en", "text": "In summary, the fundamentals of our business are strong.", "text_tts": "the fundamentals of our business are strong", "translate": "In summary, the fundamentals of our business are strong.", "translate_tts": "In summary the fundamentals of our business are strong", "is_final": false, "emotion": "😡", "events": "📞🌠👨📯🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:52:06.713", "mode": "azero-full", "language": "en", "target": "en", "text": "and we are well positioned for the long term.", "text_tts": "positioned for the long term", "translate": "and we are well positioned for the long term.", "translate_tts": "and we are well positioned for the long term", "is_final": false, "emotion": "", "events": "📞🌠👨📯🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:52:16.369", "mode": "azero-full", "language": "en", "target": "en", "text": "AbbVie has a clear runway to growth for at least the next eight years, including a high single digit revenue KEGR through twenty twenty nine.", "text_tts": "KEGR through twenty twenty nine", "translate": "AbbVie has a clear runway to growth for at least the next eight years, including a high single digit revenue KEGR through twenty twenty nine.", "translate_tts": "AbbVie has a clear runway to growth for at least the next eight years including a high single digit revenue KEGR through twenty twenty nine", "is_final": false, "emotion": "", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:52:18.858", "mode": "azero-full", "language": "en", "target": "en", "text": "With that, I'll turn the call over to Jeff", "text_tts": "ll turn the call over to Jeff", "translate": "With that, I'll turn the call over to Jeff", "translate_tts": "With that Ill turn the call over to Jeff", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "none"}
{"timestamp": "2025-07-18 11:52:21.889", "mode": "azero-full", "language": "en", "target": "en", "text": "for additional comments on our commercial highlights. Jeff?", "text_tts": "on our commercial highlights Jeff", "translate": "for additional comments on our commercial highlights. Jeff?", "translate_tts": "for additional comments on our commercial highlights Jeff", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Rob Michael (CEO)", "text_emotion": "none"}
{"timestamp": "2025-07-18 11:52:31.124", "mode": "azero-full", "language": "en", "target": "en", "text": "Thank you, Rob. I'll start with the quarterly results for Immunology, which delivered total revenues of more than six point two billion dollars, exceeding our expectations.", "text_tts": "ion dollars exceeding our expectations", "translate": "Thank you, Rob. I'll start with the quarterly results for Immunology, which delivered total revenues of more than six point two billion dollars, exceeding our expectations.", "translate_tts": "Thank you Rob Ill start with the quarterly results for Immunology which delivered total revenues of more than six point two billion dollars exceeding our expectations", "is_final": false, "emotion": "", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:52:42.316", "mode": "azero-full", "language": "en", "target": "en", "text": "SkyRizzi and Rinbok are performing exceptionally well, contributing five point one billion dollars in combined sales this quarter, reflecting growth of more than sixty five percent sign.", "text_tts": "more than sixty five percent sign", "translate": "SkyRizzi and Rinbok are performing exceptionally well, contributing five point one billion dollars in combined sales this quarter, reflecting growth of more than sixty five percent sign.", "translate_tts": "SkyRizzi and Rinbok are performing exceptionally well contributing five point one billion dollars in combined sales this quarter reflecting growth of more than sixty five percent sign", "is_final": false, "emotion": "", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:52:53.764", "mode": "azero-full", "language": "en", "target": "en", "text": "I'm especially encouraged with our portfolio performance across IBD, where Skyrizi and Renvo continue to capture significant share given their efficacy, safety and dosing profiles.", "text_tts": "heir efficacy safety and dosing profiles", "translate": "I'm especially encouraged with our portfolio performance across IBD, where Skyrizi and Renvo continue to capture significant share given their efficacy, safety and dosing profiles.", "translate_tts": "Im especially encouraged with our portfolio performance across IBD where Skyrizi and Renvo continue to capture significant share given their efficacy safety and dosing profiles", "is_final": false, "emotion": "😊", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:53:07.978", "mode": "azero-full", "language": "en", "target": "en", "text": "In Crohn's disease, which is roughly two thirds of the overall IBD market, these two treatments together are capturing roughly one out of every two in play patients in the US. And total prescription share is now in the mid teens.", "text_tts": "now in the mid teens", "translate": "In Crohn's disease, which is roughly two thirds of the overall IBD market, these two treatments together are capturing roughly one out of every two in play patients in the US. And total prescription share is now in the mid teens.", "translate_tts": "In Crohns disease which is roughly two thirds of the overall IBD market these two treatments together are capturing roughly one out of every two in play patients in the US And total prescription share is now in the mid teens", "is_final": false, "emotion": "", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:53:14.028", "mode": "azero-full", "language": "en", "target": "en", "text": "Internationally, our Chrome's portfolio has achieved in play leadership in nearly a dozen key countries.", "text_tts": "tries", "translate": "Internationally, our Chrome's portfolio has achieved in play leadership in nearly a dozen key countries.", "translate_tts": "Internationally our Chromes portfolio has achieved in play leadership in nearly a dozen key countries", "is_final": false, "emotion": "", "events": "📞🌠👨📯🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:53:15.851", "mode": "azero-full", "language": "en", "target": "en", "text": "in ulcerative colitis,", "text_tts": "in ulcerative colitis", "translate": "in ulcerative colitis,", "translate_tts": "in ulcerative colitis", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:53:22.315", "mode": "azero-full", "language": "en", "target": "en", "text": "SkyRizzi has already achieved the leading in play share in the US following the launch in the second half of last year.", "text_tts": "in the second half of last year", "translate": "SkyRizzi has already achieved the leading in play share in the US following the launch in the second half of last year.", "translate_tts": "SkyRizzi has already achieved the leading in play share in the US following the launch in the second half of last year", "is_final": false, "emotion": "", "events": "🤖🗣👨📯🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:53:31.797", "mode": "azero-full", "language": "en", "target": "en", "text": "Skyrizia and Rinvo together are now capturing one out of every three in play UC patients, a very strong leadership position for AbbVie.", "text_tts": "osition for AbbVie", "translate": "Skyrizia and Rinvo together are now capturing one out of every three in play UC patients, a very strong leadership position for AbbVie.", "translate_tts": "Skyrizia and Rinvo together are now capturing one out of every three in play UC patients a very strong leadership position for AbbVie", "is_final": false, "emotion": "", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:53:37.696", "mode": "azero-full", "language": "en", "target": "en", "text": "We are also seeing strong momentum across indications in dermatology and rheumatology as well.", "text_tts": "ology and rheumatology as well", "translate": "We are also seeing strong momentum across indications in dermatology and rheumatology as well.", "translate_tts": "We are also seeing strong momentum across indications in dermatology and rheumatology as well", "is_final": false, "emotion": "", "events": "", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:53:50.007", "mode": "azero-full", "language": "en", "target": "en", "text": "For Skyridisy, we continue to gain share in psoriatic disease, where we have achieved the leading in play share of new and switching patients in nearly thirty countries and see substantial room for total share growth.", "text_tts": "al share growth", "translate": "For Skyridisy, we continue to gain share in psoriatic disease, where we have achieved the leading in play share of new and switching patients in nearly thirty countries and see substantial room for total share growth.", "translate_tts": "For Skyridisy we continue to gain share in psoriatic disease where we have achieved the leading in play share of new and switching patients in nearly thirty countries and see substantial room for total share growth", "is_final": false, "emotion": "😊", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:54:05.144", "mode": "azero-full", "language": "en", "target": "en", "text": "For RINVOP, we are seeing increasing prescription demand globally across each of the room indications as well as additional momentum in atopic dermatitis, the fastest growing immunology market, where we have two compelling head to head studies versus", "text_tts": "ead to head studies versus", "translate": "For RINVOP, we are seeing increasing prescription demand globally across each of the room indications as well as additional momentum in atopic dermatitis, the fastest growing immunology market, where we have two compelling head to head studies versus", "translate_tts": "For RINVOP we are seeing increasing prescription demand globally across each of the room indications as well as additional momentum in atopic dermatitis the fastest growing immunology market where we have two compelling head to head studies versus", "is_final": false, "emotion": "", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:54:06.009", "mode": "azero-full", "language": "en", "target": "en", "text": "Make sense.", "text_tts": "Make sense", "translate": "Make sense.", "translate_tts": "Make sense", "is_final": false, "emotion": "", "events": "📞🌠", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:54:13.263", "mode": "azero-full", "language": "en", "target": "en", "text": "We are also preparing for the global launch of giant cell arteritis, another new source of growth for ORINVOC.", "text_tts": "arteritis another new source of growth for ORINVOC", "translate": "We are also preparing for the global launch of giant cell arteritis, another new source of growth for ORINVOC.", "translate_tts": "We are also preparing for the global launch of giant cell arteritis another new source of growth for ORINVOC", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:54:27.770", "mode": "azero-full", "language": "en", "target": "en", "text": "We received European approval earlier this month and expect FDA approval soon. The addition of this indication further rounds out Rinvoke's rheumatology label and gives patients with GCA access to a new compelling oral therapeutic option.", "text_tts": "oral therapeutic option", "translate": "We received European approval earlier this month and expect FDA approval soon. The addition of this indication further rounds out Rinvoke's rheumatology label and gives patients with GCA access to a new compelling oral therapeutic option.", "translate_tts": "We received European approval earlier this month and expect FDA approval soon The addition of this indication further rounds out Rinvokes rheumatology label and gives patients with GCA access to a new compelling oral therapeutic option", "is_final": false, "emotion": "", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:54:38.643", "mode": "azero-full", "language": "en", "target": "en", "text": "Overall, Skyrizia and Rinbok are demonstrating impressive results across all of their approved indications, and we will be raising our full year sales guidance for both products.", "text_tts": "oth products", "translate": "Overall, Skyrizia and Rinbok are demonstrating impressive results across all of their approved indications, and we will be raising our full year sales guidance for both products.", "translate_tts": "Overall Skyrizia and Rinbok are demonstrating impressive results across all of their approved indications and we will be raising our full year sales guidance for both products", "is_final": false, "emotion": "😊", "events": "🤖🗣👨📯🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:54:48.360", "mode": "azero-full", "language": "en", "target": "en", "text": "Turning now to HUMIRA, which delivered global sales of one point one billion dollars, down forty nine point five percent on an operational basis, below our expectations,", "text_tts": "al basis below our expectations", "translate": "Turning now to HUMIRA, which delivered global sales of one point one billion dollars, down forty nine point five percent on an operational basis, below our expectations,", "translate_tts": "Turning now to HUMIRA which delivered global sales of one point one billion dollars down forty nine point five percent on an operational basis below our expectations", "is_final": false, "emotion": "", "events": "🤖🗣👨📯🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "sadness"}
{"timestamp": "2025-07-18 11:54:55.687", "mode": "azero-full", "language": "en", "target": "en", "text": "primarily due to faster share erosion from biosimilar competition as well as further molecule compression in the US.", "text_tts": "ule compression in the US", "translate": "primarily due to faster share erosion from biosimilar competition as well as further molecule compression in the US.", "translate_tts": "primarily due to faster share erosion from biosimilar competition as well as further molecule compression in the US", "is_final": false, "emotion": "", "events": "👨📯📞🌠🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "sadness"}
{"timestamp": "2025-07-18 11:54:59.752", "mode": "azero-full", "language": "en", "target": "en", "text": "As a result, we will be lowering our full year sales guidance for US Chimira.", "text_tts": "guidance for US Chimira", "translate": "As a result, we will be lowering our full year sales guidance for US Chimira.", "translate_tts": "As a result we will be lowering our full year sales guidance for US Chimira", "is_final": false, "emotion": "", "events": "📞🌠👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "sadness"}
{"timestamp": "2025-07-18 11:55:05.912", "mode": "azero-full", "language": "en", "target": "en", "text": "Moving to oncology, where total revenues were one point six billion dollars, exceeding our expectations.", "text_tts": "ne point six billion dollars exceeding our expectations", "translate": "Moving to oncology, where total revenues were one point six billion dollars, exceeding our expectations.", "translate_tts": "Moving to oncology where total revenues were one point six billion dollars exceeding our expectations", "is_final": false, "emotion": "", "events": "📞🌠👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:55:14.209", "mode": "azero-full", "language": "en", "target": "en", "text": "IMBRUVICA global sales were seven hundred thirty eight million dollars, down eleven point nine percent, reflecting competitive dynamics in CLL.", "text_tts": "ng competitive dynamics in CLL", "translate": "IMBRUVICA global sales were seven hundred thirty eight million dollars, down eleven point nine percent, reflecting competitive dynamics in CLL.", "translate_tts": "IMBRUVICA global sales were seven hundred thirty eight million dollars down eleven point nine percent reflecting competitive dynamics in CLL", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:55:21.324", "mode": "azero-full", "language": "en", "target": "en", "text": "then CLEXTA global revenues were six hundred sixty five million dollars, up twelve point three percent on an operational basis.", "text_tts": "illion dollars up twelve point three percent on an operational basis", "translate": "then CLEXTA global revenues were six hundred sixty five million dollars, up twelve point three percent on an operational basis.", "translate_tts": "then CLEXTA global revenues were six hundred sixty five million dollars up twelve point three percent on an operational basis", "is_final": false, "emotion": "", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:55:32.385", "mode": "azero-full", "language": "en", "target": "en", "text": "This strong performance reflects continued momentum in CLL as well as shared leadership in frontline AML among patients who are ineligible for intensive induction chemotherapy.", "text_tts": "eligible for intensive induction chemotherapy", "translate": "This strong performance reflects continued momentum in CLL as well as shared leadership in frontline AML among patients who are ineligible for intensive induction chemotherapy.", "translate_tts": "This strong performance reflects continued momentum in CLL as well as shared leadership in frontline AML among patients who are ineligible for intensive induction chemotherapy", "is_final": false, "emotion": "", "events": "👨📯🏠🔊🤖🗣", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:55:36.632", "mode": "azero-full", "language": "en", "target": "en", "text": "We also have an emerging commercial portfolio in solid tumors.", "text_tts": "emerging commercial portfolio in solid tumors", "translate": "We also have an emerging commercial portfolio in solid tumors.", "translate_tts": "We also have an emerging commercial portfolio in solid tumors", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:55:38.460", "mode": "azero-full", "language": "en", "target": "en", "text": "This includes Ella here.", "text_tts": "Ella here", "translate": "This includes Ella here.", "translate_tts": "This includes Ella here", "is_final": false, "emotion": "", "events": "📞🌠👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:55:44.267", "mode": "azero-full", "language": "en", "target": "en", "text": "our leading ADC for ovarian cancer with global sales of one hundred seventy nine million dollars.", "text_tts": "sales of one hundred seventy nine million dollars", "translate": "our leading ADC for ovarian cancer with global sales of one hundred seventy nine million dollars.", "translate_tts": "our leading ADC for ovarian cancer with global sales of one hundred seventy nine million dollars", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:55:46.601", "mode": "azero-full", "language": "en", "target": "en", "text": "as well as ColiseoV.", "text_tts": "ColiseoV", "translate": "as well as ColiseoV.", "translate_tts": "as well as ColiseoV", "is_final": false, "emotion": "", "events": "📞🌠👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:55:56.078", "mode": "azero-full", "language": "en", "target": "en", "text": "a potential new medicine for late line non small cell lung cancer patients, with US regulatory approval and commercialization expected in the next couple of months.", "text_tts": "uple of months", "translate": "a potential new medicine for late line non small cell lung cancer patients, with US regulatory approval and commercialization expected in the next couple of months.", "translate_tts": "a potential new medicine for late line non small cell lung cancer patients with US regulatory approval and commercialization expected in the next couple of months", "is_final": false, "emotion": "", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:56:10.555", "mode": "azero-full", "language": "en", "target": "en", "text": "TelesioV will be supported by a dedicated sales force and medical affairs team, which will target academic and community cancer treatment centers to reinforce the importance of CMET as a biomarker and build relationships that support our", "text_tts": "d build relationships that support our", "translate": "TelesioV will be supported by a dedicated sales force and medical affairs team, which will target academic and community cancer treatment centers to reinforce the importance of CMET as a biomarker and build relationships that support our", "translate_tts": "TelesioV will be supported by a dedicated sales force and medical affairs team which will target academic and community cancer treatment centers to reinforce the importance of CMET as a biomarker and build relationships that support our", "is_final": false, "emotion": "", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:56:13.170", "mode": "azero-full", "language": "en", "target": "en", "text": "emerging solid tumor franchise.", "text_tts": "id tumor franchise", "translate": "emerging solid tumor franchise.", "translate_tts": "emerging solid tumor franchise", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:56:24.516", "mode": "azero-full", "language": "en", "target": "en", "text": "Turning now to Aesthetics, which delivered global sales of one point one billion dollars, down ten point two percent on an operational basis. This was in line with our expectations.", "text_tts": "al basis This was in line with our expectations", "translate": "Turning now to Aesthetics, which delivered global sales of one point one billion dollars, down ten point two percent on an operational basis. This was in line with our expectations.", "translate_tts": "Turning now to Aesthetics which delivered global sales of one point one billion dollars down ten point two percent on an operational basis This was in line with our expectations", "is_final": false, "emotion": "", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:56:31.659", "mode": "azero-full", "language": "en", "target": "en", "text": "Botox Cosmetic Global revenues were five hundred fifty six million dollars, down ten point seven percent on an operational basis", "text_tts": "seven percent on an operational basis", "translate": "Botox Cosmetic Global revenues were five hundred fifty six million dollars, down ten point seven percent on an operational basis", "translate_tts": "Botox Cosmetic Global revenues were five hundred fifty six million dollars down ten point seven percent on an operational basis", "is_final": false, "emotion": "", "events": "🤖🗣", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:56:37.571", "mode": "azero-full", "language": "en", "target": "en", "text": "and Juvederm sales were two hundred thirty one million dollars, down twenty percent on an operational basis.", "text_tts": "illion dollars down twenty percent on an operational basis", "translate": "and Juvederm sales were two hundred thirty one million dollars, down twenty percent on an operational basis.", "translate_tts": "and Juvederm sales were two hundred thirty one million dollars down twenty percent on an operational basis", "is_final": false, "emotion": "", "events": "📞🌠", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:56:43.970", "mode": "azero-full", "language": "en", "target": "en", "text": "As we have seen over the last several quarters, economic headwinds have continued to impact market conditions.", "text_tts": "headwinds have continued to impact market conditions", "translate": "As we have seen over the last several quarters, economic headwinds have continued to impact market conditions.", "translate_tts": "As we have seen over the last several quarters economic headwinds have continued to impact market conditions", "is_final": false, "emotion": "", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "sadness"}
{"timestamp": "2025-07-18 11:56:55.790", "mode": "azero-full", "language": "en", "target": "en", "text": "Based on the trends we are seeing, including a decline in recent consumer sentiment, we are moderating our assumptions for category growth globally and adjusting our full year sales guidance for aesthetics accordingly.", "text_tts": "guidance for aesthetics accordingly", "translate": "Based on the trends we are seeing, including a decline in recent consumer sentiment, we are moderating our assumptions for category growth globally and adjusting our full year sales guidance for aesthetics accordingly.", "translate_tts": "Based on the trends we are seeing including a decline in recent consumer sentiment we are moderating our assumptions for category growth globally and adjusting our full year sales guidance for aesthetics accordingly", "is_final": false, "emotion": "", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "sadness"}
{"timestamp": "2025-07-18 11:57:02.799", "mode": "azero-full", "language": "en", "target": "en", "text": "While near term aesthetics market conditions remain challenging, the long term prospects for the category remain attractive.", "text_tts": "attractive", "translate": "While near term aesthetics market conditions remain challenging, the long term prospects for the category remain attractive.", "translate_tts": "While near term aesthetics market conditions remain challenging the long term prospects for the category remain attractive", "is_final": false, "emotion": "", "events": "📞🌠👨📯🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:57:07.208", "mode": "azero-full", "language": "en", "target": "en", "text": "given high consumer interest and low penetration rates for facial injectables.", "text_tts": "facial injectables", "translate": "given high consumer interest and low penetration rates for facial injectables.", "translate_tts": "given high consumer interest and low penetration rates for facial injectables", "is_final": false, "emotion": "", "events": "📞🌠👨📯🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:57:10.026", "mode": "azero-full", "language": "en", "target": "en", "text": "I'm particularly excited about Bon T.", "text_tts": "excited about Bon T", "translate": "I'm particularly excited about Bon T.", "translate_tts": "Im particularly excited about Bon T", "is_final": false, "emotion": "😊", "events": "📞🌠👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:57:11.736", "mode": "azero-full", "language": "en", "target": "en", "text": "are fast acting.", "text_tts": "acting", "translate": "are fast acting.", "translate_tts": "are fast acting", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:57:26.551", "mode": "azero-full", "language": "en", "target": "en", "text": "short duration toxin, which we recently submitted for US regulatory review. This first in class toxin represents a distinctive innovation for the treatment of globellar lines and has the potential to be an important catalyst for new patient activation", "text_tts": "an important catalyst for new patient activation", "translate": "short duration toxin, which we recently submitted for US regulatory review. This first in class toxin represents a distinctive innovation for the treatment of globellar lines and has the potential to be an important catalyst for new patient activation", "translate_tts": "short duration toxin which we recently submitted for US regulatory review This first in class toxin represents a distinctive innovation for the treatment of globellar lines and has the potential to be an important catalyst for new patient activation", "is_final": false, "emotion": "", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:57:28.471", "mode": "azero-full", "language": "en", "target": "en", "text": "into the facial aesthetics category.", "text_tts": "aesthetics category", "translate": "into the facial aesthetics category.", "translate_tts": "into the facial aesthetics category", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:57:31.036", "mode": "azero-full", "language": "en", "target": "en", "text": "We anticipate commercialization next year.", "text_tts": "ization next year", "translate": "We anticipate commercialization next year.", "translate_tts": "We anticipate commercialization next year", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:57:43.657", "mode": "azero-full", "language": "en", "target": "en", "text": "Moving now to neuroscience, where total revenues were approximately two point three billion dollars, up seventeen percent on an operational basis with all key products exceeding our expectations.", "text_tts": "s with all key products exceeding our expectations", "translate": "Moving now to neuroscience, where total revenues were approximately two point three billion dollars, up seventeen percent on an operational basis with all key products exceeding our expectations.", "translate_tts": "Moving now to neuroscience where total revenues were approximately two point three billion dollars up seventeen percent on an operational basis with all key products exceeding our expectations", "is_final": false, "emotion": "", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:57:53.559", "mode": "azero-full", "language": "en", "target": "en", "text": "RayLar Global sales were seven hundred sixty five million dollars, up ten point three percent, reflecting share capture in both bipolar I disorder and adjunctive major depression.", "text_tts": "rcent reflecting share capture in both bipolar I disorder and adjunctive major depression", "translate": "RayLar Global sales were seven hundred sixty five million dollars, up ten point three percent, reflecting share capture in both bipolar I disorder and adjunctive major depression.", "translate_tts": "RayLar Global sales were seven hundred sixty five million dollars up ten point three percent reflecting share capture in both bipolar I disorder and adjunctive major depression", "is_final": false, "emotion": "", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:58:03.679", "mode": "azero-full", "language": "en", "target": "en", "text": "We continue to get very positive feedback on Vrailar's profile in terms of dosing flexibility, low sedation and the ability to treat a full spectrum of symptoms.", "text_tts": "y to treat a full spectrum of symptoms", "translate": "We continue to get very positive feedback on Vrailar's profile in terms of dosing flexibility, low sedation and the ability to treat a full spectrum of symptoms.", "translate_tts": "We continue to get very positive feedback on Vrailars profile in terms of dosing flexibility low sedation and the ability to treat a full spectrum of symptoms", "is_final": false, "emotion": "😊", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:58:13.415", "mode": "azero-full", "language": "en", "target": "en", "text": "We are very competitively positioned with our migraine portfolio, where all three of our therapies continue to deliver double digit operational growth.", "text_tts": "continue to deliver double digit operational growth", "translate": "We are very competitively positioned with our migraine portfolio, where all three of our therapies continue to deliver double digit operational growth.", "translate_tts": "We are very competitively positioned with our migraine portfolio where all three of our therapies continue to deliver double digit operational growth", "is_final": false, "emotion": "😊", "events": "🤖🗣", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:58:19.171", "mode": "azero-full", "language": "en", "target": "en", "text": "BOTOX therapeutic global revenues were eight hundred sixty six million dollars, up seventeen percent.", "text_tts": "sixty six million dollars up seventeen percent", "translate": "BOTOX therapeutic global revenues were eight hundred sixty six million dollars, up seventeen percent.", "translate_tts": "BOTOX therapeutic global revenues were eight hundred sixty six million dollars up seventeen percent", "is_final": false, "emotion": "", "events": "📞🌠👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:58:24.390", "mode": "azero-full", "language": "en", "target": "en", "text": "Yubrelvi global sales were two hundred forty million dollars, up eighteen percent.", "text_tts": "ollars up eighteen percent", "translate": "Yubrelvi global sales were two hundred forty million dollars, up eighteen percent.", "translate_tts": "Yubrelvi global sales were two hundred forty million dollars up eighteen percent", "is_final": false, "emotion": "😰", "events": "📞🌠👨📯🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:58:29.599", "mode": "azero-full", "language": "en", "target": "en", "text": "and Cualypta Global revenues were one hundred ninety three million dollars, up forty eight point three percent.", "text_tts": "ty three million dollars up forty eight point three percent", "translate": "and Cualypta Global revenues were one hundred ninety three million dollars, up forty eight point three percent.", "translate_tts": "and Cualypta Global revenues were one hundred ninety three million dollars up forty eight point three percent", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:58:35.297", "mode": "azero-full", "language": "en", "target": "en", "text": "And in Parkinson's disease, Violev global sales were sixty three million dollars.", "text_tts": "were sixty three million dollars", "translate": "And in Parkinson's disease, Violev global sales were sixty three million dollars.", "translate_tts": "And in Parkinsons disease Violev global sales were sixty three million dollars", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:58:38.250", "mode": "azero-full", "language": "en", "target": "en", "text": "reflecting continued strong uptake in Japan and Europe.", "text_tts": "uptake in Japan and Europe", "translate": "reflecting continued strong uptake in Japan and Europe.", "translate_tts": "reflecting continued strong uptake in Japan and Europe", "is_final": false, "emotion": "", "events": "📞🌠🏠🔊", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:58:50.953", "mode": "azero-full", "language": "en", "target": "en", "text": "We are also pleased with the early launch feedback in the US, where revenues are expected to ramp gradually over the next couple of quarters as we work to establish the appropriate Medicare coverage and benefit determination.", "text_tts": "determination", "translate": "We are also pleased with the early launch feedback in the US, where revenues are expected to ramp gradually over the next couple of quarters as we work to establish the appropriate Medicare coverage and benefit determination.", "translate_tts": "We are also pleased with the early launch feedback in the US where revenues are expected to ramp gradually over the next couple of quarters as we work to establish the appropriate Medicare coverage and benefit determination", "is_final": false, "emotion": "😊", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
{"timestamp": "2025-07-18 11:59:06.542", "mode": "azero-full", "language": "en", "target": "en", "text": "Lastly, we are making excellent progress with the development of tevapadon in Parkinson's disease. This first in class D one D five selective dopamine agonist has a favorable benefit risk profile and the potential to differentiate in several", "text_tts": "ial to differentiate in several", "translate": "Lastly, we are making excellent progress with the development of tevapadon in Parkinson's disease. This first in class D one D five selective dopamine agonist has a favorable benefit risk profile and the potential to differentiate in several", "translate_tts": "Lastly we are making excellent progress with the development of tevapadon in Parkinsons disease This first in class D one D five selective dopamine agonist has a favorable benefit risk profile and the potential to differentiate in several", "is_final": false, "emotion": "😊", "events": "🤖🗣👨📯", "think": "", "wav_name": "b5a761d0-948a-426e-8830-3ec3bd6c7e1c", "embedding": [0.0, 0.0], "reserved": "", "speaker": "Jeff Stewart (Chief Commercial Officer)", "text_emotion": "happiness"}
End of preview. Expand in Data Studio

EmoAlignBench Raw Dataset: Multimodal Financial Earnings Calls

Welcome to the raw dataset repository for EmoAlignBench. This dataset contains foundational multimodal data (audio, transcripts, and dual-track emotion annotations) from corporate earnings calls. It is specifically curated for analyzing emotion incongruence—the discrepancy between textual semantics and vocal prosody—within financial discourse.

📂 Repository Structure

The dataset is organized into parallel directories named by corporate Tickers. Each directory contains the raw audio, a metadata index, emotion-tagged transcripts (JSONL), and historical stock data.

.
├── TICKER/
│   ├── {uid}_Index.json            # Metadata index linking all modal files
│   ├── {uid}_Emotion.txt           # JSONL transcript with textual & vocal emotion tags
│   ├── {uid}.m4a                   # Raw audio file (or .mp3 / .wav)
│   └── {uid}_Stockprice.json       # Daily historical stock prices and volumes
└── README.md

📄 Data Formats & Fields

1. Metadata Index (*_Index.json)

Links the disparate data files for a specific earnings call event.

{
  "uid": "ABBV_20250425_EC",            // Unique event identifier
  "ticker": "ABBV",                     // Stock ticker symbol
  "event_start_et": "2025-04-25 09:00", // Event start time (US Eastern Time)
  "sound_file": "ABBV_20250425.m4a",    // Reference to the audio file
  "transcript_sound": "...Emotion.txt", // Reference to the emotion transcript
  "stock_price": "...Stockprice.json"   // Reference to the stock data
}

2. Emotion Transcripts (*_Emotion.txt)

A JSON-Lines file where each line is an utterance with synchronized timestamps and emotion labels.

{
  "speaker": "Analyst Name",            // Identity of the speaker
  "timestamp": "2025-04-25 09:15:20",   // Start time for audio alignment
  "text": "The margin pressure is...",  // Raw transcript text
  "text_emotion": "fear",               // Textual Emotion Label (fear, joy, none, etc.)
  "emotion": "😰",                      // Vocal Emotion emoji (😰, 😊, none, etc.)
  "events": ""                          // Auxiliary symbolic markers
}

3. Stock Price Data (*_Stockprice.json)

Standard daily time series data containing historical context around the call date.

{
  "Meta Data": { "2. Symbol": "ABBV", ... }, 
  "Time Series (Daily)": {                   
    "2025-04-25": {
      "1. open": "165.20",
      "2. high": "168.50",
      "3. low": "164.10",
      "4. close": "167.30",
      "5. volume": "5200300"
    }
  }
}

📝 License

This dataset is licensed under the Apache License 2.0.

Downloads last month
-